Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2105-2112
Published online before print April 24, 2006, doi: 10.1161/CIRCULATIONAHA.105.593046
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/17/2105    most recent
CIRCULATIONAHA.105.593046v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yilmaz, G.
Right arrow Articles by Granger, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yilmaz, G.
Right arrow Articles by Granger, D. N.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Genetically altered mice
Right arrow Growth factors/cytokines
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction
Right arrow Risk Factors for Stroke

(Circulation. 2006;113:2105-2112.)
© 2006 American Heart Association, Inc.


Stroke

Role of T Lymphocytes and Interferon-{gamma} in Ischemic Stroke

Gokhan Yilmaz, MD*; Thiruma V. Arumugam, PhD*; Karen Y. Stokes, PhD; D. Neil Granger, PhD

From the Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport.

Correspondence to D. Neil Granger, PhD, Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, 1501 Kings Hwy, Shreveport, LA 71130-3932. E-mail dgrang{at}lsuhsc.edu

Received October 4, 2005; revision received January 11, 2006; accepted March 1, 2006.

Background— Although lymphocyte recruitment and activation are associated with cerebral ischemia-reperfusion (I/R) injury, the contributions of specific lymphocyte subpopulations and lymphocyte-derived interferon-{gamma} (IFN-{gamma}) to stroke remain unknown. The objectives of this study were to define the contribution of specific populations of lymphocytes to the inflammatory and prothrombogenic responses elicited in the cerebral microvasculature by I/R and to investigate the role of T-cell–associated IFN-{gamma} in the pathogenesis of ischemic stroke.

Methods and Results— Middle cerebral artery occlusion was induced for 1 hour (followed by 4 or 24 hours of reperfusion) in wild-type mice and mice deficient in lymphocytes (Rag1–/–), CD4+ T cells, CD8+ T cells, B cells, or IFN-{gamma}. Platelet and leukocyte adhesion was assessed in cortical venules with intravital video microscopy. Neurological deficit and infarct volume were determined 24 hours after reperfusion. Rag1–/–, CD4+ T-cell–/–, CD8+ T-cell–/–, and IFN-{gamma}–/– mice exhibited comparable significant reductions in I/R-induced leukocyte and platelet adhesion compared with wild-type mice exposed to I/R. Infarct volume was reduced and I/R-induced neurological deficit was improved in immunodeficient Rag1–/– mice. These protective responses were reversed in Rag1–/– mice reconstituted with either wild-type or, to a lesser extent, IFN-{gamma}–/– splenocytes. B-cell–deficient mice failed to show improvement against ischemic stroke injury.

Conclusions— These findings indicate that CD4+ and CD8+ T lymphocytes, but not B lymphocytes, contribute to the inflammatory and thrombogenic responses, brain injury, and neurological deficit associated with experimental stroke. Although IFN-{gamma} plays a pivotal role in stroke-induced inflammatory responses, T lymphocytes appear to be a minor source of this cytokine.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
StrokeHome page
S. Terao, G. Yilmaz, K. Y. Stokes, M. Ishikawa, T. Kawase, and D. N. Granger
Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice
Stroke, March 1, 2008; 39(3): 943 - 950.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Ishikawa, E. Sekizuka, N. Yamaguchi, H. Nakadate, S. Terao, D. N. Granger, and H. Minamitani
Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2306 - H2315.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. E. Baird
Blood Genomics in Human Stroke
Stroke, February 1, 2007; 38(2): 694 - 698.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. Dirnagl, J. Klehmet, J. S. Braun, H. Harms, C. Meisel, T. Ziemssen, K. Prass, and A. Meisel
Stroke-Induced Immunodepression: Experimental Evidence and Clinical Relevance
Stroke, February 1, 2007; 38(2): 770 - 773.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. M. Gee, A. Kalil, C. Shea, and K. J. Becker
Lymphocytes: Potential Mediators of Postischemic Injury and Neuroprotection
Stroke, February 1, 2007; 38(2): 783 - 788.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. E. Baird
The Forgotten Lymphocyte: Immunity and Stroke
Circulation, May 2, 2006; 113(17): 2035 - 2036.
[Full Text] [PDF]